GenMont Biotech Incorporation (TPE:3164)
16.50
+0.10 (0.61%)
Jul 14, 2026, 1:30 PM CST
-20.67% (1Y)
| Market Cap | 1.42B -17.2% |
| Revenue (ttm) | 390.95M +6.1% |
| Net Income | 44.89M +15.2% |
| EPS | 0.52 +15.6% |
| Shares Out | 86.01M |
| PE Ratio | 31.72 |
| Forward PE | n/a |
| Dividend | 0.80 (4.88%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 2,194 |
| Open | 16.50 |
| Previous Close | 16.40 |
| Day's Range | 16.40 - 16.50 |
| 52-Week Range | 15.90 - 22.40 |
| Beta | 0.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |